Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 June 2020: Clinical Research

LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis

Ying Wang CDE* , Danli Xin ABCE , Lei Zhou BCDF

DOI: 10.12659/MSM.920886

Med Sci Monit 2020; 26:e920886

Figure 5 MiR-613 regulated YAP1 expression in retinoblastoma cells. (A) The binding sequences between 3′UTR of YAP1 and miR-613 were predicted by bioinformatics software starBase. (B, C) Dual-luciferase reporter assay was used to assess luciferase activity in Y79 and Weri-RB-1 cells. (D–G) The mRNA and protein expression levels of YAP1 in Y79 and Weri-RB-1 cells introduced with miR-613, miR-NC, anti-miR-613, or anti-miR-NC were measured by RT-qPCR and western blot, respectively. (H) RT-qPCR analysis was used to measure the mRNA expression level of YAP1 in retinoblastoma tissues and normal retina tissues. (I) Correlation analysis between miR-613 and YAP1 was conducted. ** P<0.01. RT-qPCR – real-time quantitative polymerase chain reaction.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750